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tis, pouch surgery is the major challenge, especially if complica-
tions occur. By special expertise, control can be achieved in most 
cases, thus providing a normal quality of life postoperatively. The 
clinical decision making at the crossroad between internal medi-
cine and surgery is still the subject of an ongoing intense and par-
tially controversial interdisciplinary debate, and this topic is re-
flected by the interdisciplinary team of authors as well as by the 
interdisciplinary discussion in this special issue.
Many improvements in the medical therapy of inflammatory 
bowel diseases have been accomplished in recent years. Starting 
with the era of anti-TNF (tumor necrosis factor) agents, additional 
immunosuppressive or anti-inflammatory biological agents block-
ing proinflammatory cytokines and signaling or adhesion mole-
cules have been developed and tested for the therapy of inflamma-
tory bowel diseases in the context of randomized controlled clini-
cal trials. As highlighted in this issue of Viszeralmedizin, this has 
led to changes in many of our guidelines for the therapy of inflam-
matory bowel diseases. Moreover, new surgical techniques have 
been developed in order to optimize patient care in those affected 
by inflammatory bowel diseases. It was therefore the vision of the 
editors to dedicate this issue to an update on the current medical 
and surgical management of inflammatory bowel diseases. Key 
gastroenterological and surgical topics are covered by renowned 
international experts. We hope to provide a stimulating special 
issue by covering key clinical aspects of this fascinating field.
The current edition of Viszeralmedizin addresses the topic of 
inflammatory bowel diseases with a special focus on the clinical 
management of these disorders. Inflammatory bowel diseases com-
prise Crohn’s disease and ulcerative colitis, which are characterized 
by episodes of abdominal cramping, pain, and chronic diarrhea. 
The incidence of inflammatory bowel diseases seems to increase in 
Western countries, and physicians are frequently challenged by the 
clinical complications of chronic intestinal inflammation in pa-
tients with inflammatory bowel diseases. Such complications in-
clude the presence of strictures, stenoses, abscess formation, fistu-
las, and the development of colitis-associated neoplasias and can-
cer. It is therefore not surprising that inflammatory bowel diseases 
place a significant burden on the health care systems and are asso-
ciated with augmented morbidity and health care costs. Finally, 
these diseases may cause a marked impairment of the quality of life 
in affected patients.
The early detection and optimized therapy of inflammatory 
bowel diseases are of utmost importance for the prevention of 
complications of the disease. These topics are addressed by the 
 invited articles and the interdisciplinary discussion in this issue of 
Viszeralmedizin. However, many patients still require surgery 
for the treatment of complications of these disorders. Surgery has 
to follow certain principles in order to be successful: In Crohn’s 
disease, operative treatment should be performed in a gut-sparing 
technique and only in the case of complications. In ulcerative coli-
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